Upgrade to SI Premium - Free Trial

Rhythm Pharmaceuticals (RYTM) Tops Q3 EPS by 3c

November 1, 2019 8:36 AM
Rhythm Pharmaceuticals (NASDAQ: RYTM) reported Q3 EPS of ($1.04), $0.03 better than the analyst estimate of ($1.07).Announced Positive Topline Results ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Management Comments

Next Articles